Catalytic and non-catalytic functions of human IIA phospholipase A2

Trends in Biochemical Sciences

Volumn 35, Issue 1, 2010, Pages 28-35

  Birts, Charles N ^a   Barton, C Howard ^a   Wilton, David C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; PHOSPHOLIPASE A2 GROUP IIA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CARDIOVASCULAR DISEASE; CATALYSIS; CELL TRANSPORT; ENZYME STRUCTURE; GRAM POSITIVE BACTERIUM; HUMAN; HYDROLYSIS; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; MACROPHAGE; NEOPLASM; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN TRANSPORT; REVIEW; RHEUMATOID ARTHRITIS;

ACUTE-PHASE PROTEINS; ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; GROUP II PHOSPHOLIPASES A2; HUMANS; INFLAMMATION;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 73649088003     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2009.08.003     Document Type: Review

References (67)

1. Lambeau G., and Gelb M.H. Biochemistry and physiology of mammalian secreted phospholipases A(2). Ann. Rev. Biochem. 77 (2008) 495-520
2. Schaloske R.H., and Dennis E.A. The phospholipase A(2) superfamily and its group numbering system. Biochim. Biophys. Acta 1761 (2006) 1246-1259
3. Pruzanski W., et al. Phospholipase-A2 Activity in Sera and Synovial-Fluids in Rheumatoid-Arthritis and Osteo-Arthritis - Its Possible Role As A Proinflammatory Enzyme. J. Rheumatol. 12 (1985) 211-216
4. Ghosh M., et al. Properties of the Group IV phospholipase A(2) family. Prog. Lipid Res. 45 (2006) 487-510
5. Wery J.P., et al. Structure of recombinant human rheumatoid arthritic synovial-fluid phospholipase-A2 at 2.2 A resolution. Nature 352 (1991) 79-82
6. Scott D.L., et al. Structures of free and inhibited human secretory phospholipase-a2 from inflammatory exudate. Science 254 (1991) 1007-1010
7. Crowl R.M., et al. Induction of phospholipase-A2 gene-expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266 (1991) 2647-2651
8. Berg O.G., et al. Interfacial enzymology: The secreted phospholipase A(2)- paradigm. Chem. Rev. 101 (2001) 2613-2653
9. Murakami M., and Kudo I. Diversity and regulatory functions of mammalian secretory phospholipase A(2)s. Adv. Immunol. 77 (2001) 163-194
10. Capper E.A., and Marshall L.A. Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog. Lipid Res. 40 (2001) 167-197
11. Triggiani M., et al. Activation of human inflammatory cells by secreted phospholipases A(2). Biochim. Biophys. Acta 1761 (2006) 1289-1300
12. Menschikowski M., et al. Secretory phospholipase A(2) of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?. Prostag. Oth. Lipid Mediat. 79 (2006) 1-33
13. Boyanovsky B.B., and Webb N.R. Biology of Secretory Phospholipase A(2). Cardiovasc. Drugs Ther. 23 (2009) 61-72
14. Edwards S.H., et al. The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A(2) at 1.5 angstrom resolution provides an insight into the catalytic mechanism. Biochemistry 41 (2002) 15468-15476
15. Birts C.N., et al. A catalytically independent physiological function for human acute phase protein group IIA phospholipase A(2) - Cellular uptake facilitates cell debris removal. J. Biol. Chem. 283 (2008) 5034-5045
16. Scott D.L., et al. The electrostatic basis for the interfacial binding of secretary phospholipases a(2). Biophys. J. 67 (1994) 493-504
17. Canaan S., et al. Unusual mode of binding of human group IIA secreted phospholipase A(2) to anionic interfaces as studied by continuous wave and time domain electron paramagnetic resonance spectroscopy. J. Biol. Chem. 277 (2002) 30984-30990
18. Bezzine S., et al. On the binding preference of human groups IIA and X phospholipases A(2) for membranes with anionic phospholipids. J. Biol. Chem. 277 (2002) 48523-48534
19. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nature Struct. Biol. 3 (1996) 842-848
20. Gelb M.H., et al. Interfacial binding of secreted phospholipases A2: more than electrostatics and a major role for tryptophan. Curr. Opin. Struct. Biol. 9 (1999) 428-432
21. Beers S.A., et al. Effect of tryptophan insertions on the properties of the human group IIA phospholipase A(2): Mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A(2). Biochemistry 42 (2003) 7326-7338
22. Qu X.D., and Lehrer R.I. Secretory phospholipase A(2) is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 66 (1998) 2791-2797
23. Koduri R.S., et al. Action of human group IIa secreted phospholipase A(2) on cell membranes - Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme. J. Biol. Chem. 273 (1998) 32142-32153
24. Enomoto A., et al. Internalization and degradation of type IIA phospholipase A(2) in mast cells. Biochem. Biophys. Res. Commun. 276 (2000) 667-672
25. Boilard E., et al. Interaction of low molecular weight group IIA phospholipase A(2) with apoptotic human T cells: role of heparan sulfate proteoglycans. FASEB J. 17 (2003) 1068-1080
26. Murakami M., et al. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A(2)s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276 (2001) 10083-10096
27. Mounier C.M., et al. Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha. J. Biol. Chem. 279 (2004) 25024-25038
28. Jaross W., et al. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Eur. J. Clin. Inves. 32 (2002) 383-393
29. Niessen H.W.M., et al. Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?. Cardiovasc. Res. 60 (2003) 68-77
30. Talvinen K.A., et al. Expression of group II phospholipase A2 in the liver in acute pancreatitis. Scand. J. Gastroenterol. 36 (2001) 1217-1221
31. Nevalainen T.J., et al. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab. Invest. 74 (1996) 585-591
32. Harwig S.S.L., et al. Bactericidal properties of murine intestinal phospholipase A(2). J. Clin. Invest. 95 (1995) 603-610
33. Nevalainen T.J., et al. Expression of group-ll phospholipase-A2 in the human gastrointestinal-tract. Lab. Invest. 72 (1995) 201-208
34. Qu X.D., et al. Secretion of type II phospholipase A(2) and cryptdin by rat small intestinal paneth cells. Infect. Immun. 64 (1996) 5161-5165
35. Yoshikawa T., et al. Cellular localization of group IIA phospholipase A(2) in rats. J. Histochem. Cytochem. 49 (2001) 777-782
36. Nevalainen T.J., et al. Secretion of group 2 phospholipase A-2 by lacrimal glands. Invest. Ophthalmol. Vis. Sci. 35 (1994) 417-421
37. Nevalainen T.J., et al. Synovial-type (group -II) phospholipase-A2 human seminal plasma. Andrologia 25 (1993) 355-358
38. Buckland A.G., and Wilton D.C. The antibacterial properties of secreted phospholipases A(2). Biochim. Biophys. Acta 1488 (2000) 71-82
39. Nevalainen T.J., et al. Antibacterial actions of secreted phospholipases A(2). Review. Biochim. Biophys. Acta 1781 (2008) 1-9
40. Foreman-Wykert A.K., et al. Cell-wall determinants of the bactericidal action of group IIA phospholipase A(2) against Gram-positive bacteria. J. Clin. Inves. 103 (1999) 715-721
41. Weiss J., et al. Determinant of the action of phospholipases A on the envelope phospholipids of Echerichia coli. J. Biol. Chem. 254 (1979) 11010-11014
42. Forst S., et al. The role of phospholipase-A2 lysines in phospholipolysis of Escherichia coli killed by a membrane active neutrophil protein. J. Biol. Chem. 257 (1982) 4055-4057
43. Weiss J., et al. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A(2) in concert with polymorphonuclear leukocytes. J. Biol. Chem. 269 (1994) 26331-26337
44. Wiese A., et al. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 36 (1997) 10301-10310
45. Wiese A., et al. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry 36 (1997) 10311-10319
46. Wilton D.C. A continuous fluorescence displacement assay for the measurement of phospholipase-A2 and other lipases that release long-chain fatty acids. Biochem. J. 266 (1990) 435-439
47. Buckland A.G., et al. Bacterial cell membrane hydrolysis by secreted phospholipases A2: a major physiological role of human group IIa sPLA2 involving both bacterial cell wall penetration and interfacial catalysis. Biochim. Biophys. Acta 1484 (2000) 195-206
48. Foreman-Wykert A.K., et al. Phospholipid synthesis by Staphylococcus aureus during (sub)lethal attack by mammalian 14-kilodalton group IIA phospholipase A2. Infect. Immun. 68 (2000) 1259-1264
49. Beers S.A., et al. The antibacterial properties of secreted phospholipases A(2) - A major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J. Biol. Chem. 277 (2002) 1788-1793
50. Koprivnjak T., et al. Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A(2) against Staphylococcus aureus. J. Biol. Chem. 277 (2002) 47636-47644
51. Peschel A. How do bacteria resist human antimicrobial peptides?. Trends Microbiol. 10 (2002) 179-186
52. Neuhaus F.C., and Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67 (2003) 686-723
53. Peschel A., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193 (2001) 1067-1076
54. Laine V.O., et al. Protection by group II phospholipase A(2) against Staphylococcus aureus. J. Immunol. 162 (1999) 7402-7408
55. Laine V.J.O., et al. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection. Infect. Immun. 68 (2000) 87-92
56. Piris-Gimenez A., et al. In vivo protective role of human group IIA phospholipase A(2) against experimental anthrax. J. Immunol. 175 (2005) 6786-6791
57. Femling J.K., et al. Synergy between extracellular group IIA phospholipase A(2) and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils. J. Immunol. 175 (2005) 4653-4661
58. Edwards I.J., et al. Differentiated macrophages synthesize a hepapan-sulphate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein-lipase. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 400-409
59. Melikov K., and Chernomordik L.V. Arginine-rich cell penetrating peptides: From endosomal uptake to nuclear delivery. Cell. Mol. Life Sci. 62 (2005) 2739-2749
60. Distler J.H.W., et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc. Nat. Acad. Sci. 102 (2005) 2892-2897
61. Leung S.Y., et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Nat. Acad. Sci. U. S. A. 99 (2002) 16203-16208
62. Kim H.K., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Cancer 39 (2003) 184-191
63. Mostefai H.A., et al. Plasma membrane microparticles in angiogenesis: Role in ischemic diseases and in cancer. Physiol. Res. 57 (2008) 311-320
64. Fourcade O., et al. Secretory phospholipase a(2) generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (1995) 919-927
65. Hack C.E., et al. A role for secretory phospholipase A(2) and C-reactive protein in the removal of injured cells. Immunology Today 18 (1997) 111-115
66. Saegusa J., et al. Pro-inflammatory secretory phospholipase a2 type IIA binds to integrins alpha v beta 3 and alpha 4 beta 1 and induces proliferation of monocytic cells in an integrin-dependent manner. J. Biol. Chem. 283 (2008) 26107-26115
67. Bahnson B.J. Structure, function and interfacial allosterism in phospholipase A2: insight from the anion-assisted dimer. Arch. Biochem. Biophys. 433 (2005) 96-106